As per MRFR analysis, the South Korea Post-Traumatic Stress Disorder Market Size was estimated at 440.25 (USD Million) in 2023. The South Korea Post-Traumatic Stress Disorder Market Industry is expected to grow from 461.75(USD Million) in 2024 to 1,048.58 (USD Million) by 2035. The South Korea Post-Traumatic Stress Disorder Market CAGR (growth rate) is expected to be around 7.741% during the forecast period (2025 - 2035).
Key South Korea Post-Traumatic Stress Disorder Market Trends Highlighted
Growing knowledge and understanding of mental health issues are driving notable trends in the South Korea Post-Traumatic Stress Disorder Market. In response to the growing prevalence of PTSD among people exposed to traumatic events, as those impacted by the Sewol ferry disaster, the South Korean government has been aggressively supporting mental health efforts. Since they make resources for therapy and counselling services more accessible to the general public, increased government financing and support for mental health services have been important market drivers. As new developments in telehealth services offer creative approaches to offering mental health support, opportunities in the South Korean market are growing.
Patients can now receive therapy and counselling remotely due to the growth of digital platforms, which successfully overcomes obstacles like stigma and geographic restrictions. In order to meet the various needs of patients, the medical landscape is increasingly reliant on digital technologies. Recent trends show that technology businesses and healthcare providers are working together more and more to create apps and online services aimed at managing PTSD. With younger generations becoming more receptive to talking about mental wellness and accepting therapy, South Korea's traditional approach to mental health is changing.
Furthermore, there is an increasing need for integrated mental health services and community-based support networks as a result of the COVID-19 pandemic's consequences, which have raised awareness of mental health issues. The public is becoming more knowledgeable as a result of South Korea's shifting mental health narrative, which may encourage more people to seek PTSD treatment.
Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review
South Korea Post-Traumatic Stress Disorder Market Drivers
Growing Awareness and Education about Mental Health
In South Korea, the increasing awareness and education regarding mental health have significantly influenced the South Korea Post-Traumatic Stress Disorder Market Industry. Campaigns initiated by the Ministry of Health and Welfare have led to a heightened understanding of mental health issues, including Post-Traumatic Stress Disorder (PTSD). Statistics indicate that 1 in 10 South Koreans experience a mental health issue within their lifetime, according to the Korea National Health and Nutrition Examination Survey.This surge in awareness is fostering early diagnosis and treatment, thereby expanding the market for PTSD-related therapies and medications.
Additionally, various NGOs and academic institutions are conducting seminars, which not only inform the public but also enhance the visibility of PTSD, paving the way for more robust investments in treatment and care methods, thus propelling the market growth considerably.
Increase in PTSD Cases Due to Natural Disasters and Social Tensions
Natural disasters like the 2016 earthquake in Gyeongju and continued social tensions due to geopolitical events have contributed to a substantial rise in the number of PTSD cases in South Korea. Reports from the Korean Society of Traumatic Stress Studies indicate that the incidence of PTSD has increased by approximately 15% among individuals who experienced these traumatic events.
Consequently, this rise necessitates effective therapeutic interventions and medication, inherently driving the demand within the South Korea Post-Traumatic Stress Disorder Market Industry.The prevalence of PTSD in the population is pushing healthcare providers and pharmaceutical companies to invest in innovative treatment solutions.
Government Initiatives and Funding for Mental Health Services
The South Korean government has been increasingly recognizing the importance of addressing mental health issues, including PTSD. In recent years, they have allocated significant funding to improve mental health services and treatment facilities. As part of the 'Mental Health Act' amendments, the government has authorized a budget increase of over 200 billion Korean won (approximately 170 million USD) for mental health initiatives in the public health system.These initiatives aim to provide better support for individuals who have PTSD, thereby expanding the South Korea Post-Traumatic Stress Disorder Market Industry.
This government backing ensures that more resources are available for research, development, and the expansion of treatment options, encouraging further market growth.
Advancements in Treatment Technologies and Pharmaceuticals
The South Korea Post-Traumatic Stress Disorder Market Industry is experiencing growth due to technological advancements in treatment options. The pharmaceutical sector is observing an increase in Research and Development (R&D) activities aimed at developing innovative therapies and medications for PTSD. For instance, companies like Samsung Bioepis are focusing on biologics that could improve treatment outcomes for people with PTSD.
According to the Ministry of Food and Drug Safety, there has been a 30% increase in approvals for PTSD-related therapeutic drugs over the last four years. This trend in technological evolution and therapeutic advancements is creating a positive impact on the market, as more effective and personalized treatment solutions become available, encouraging more individuals to seek help.
South Korea Post-Traumatic Stress Disorder Market Segment Insights
Post-Traumatic Stress Disorder Market Treatment Insights
The Treatment segment of the South Korea Post-Traumatic Stress Disorder Market is critical in addressing the mental health challenges faced by individuals who have PTSD. This segment encompasses various approaches and therapies that are designed to alleviate symptoms and improve the quality of life for patients. Among these, Prazosin is highlighted for its effectiveness in managing nightmares and sleep disturbances commonly associated with PTSD, making it particularly important for patients who experience these symptoms. Anti-anxiety medications serve as another significant component, offering relief from the pervasive anxiety and stress that often accompany the disorder. These medications play a vital role in stabilizing individuals, allowing them to engage constructively in their recovery process.
Moreover, psychotherapy is a cornerstone of treatment, providing patients with coping strategies and a supportive environment to process their traumatic experiences. The incorporation of various therapeutic modalities, such as cognitive behavioral therapy and exposure therapy, allows for tailored treatments that address the unique needs of patients. Medications are also widely utilized in conjunction with therapeutic approaches to provide comprehensive care, ensuring that both the psychological and physiological aspects of PTSD are managed effectively.
Finally, other treatment options, including alternative therapies and lifestyle modifications, are gaining traction as part of a holistic approach to mental health care in South Korea. The increasing recognition of mental health issues has led to a supportive environment where treatment options are continually evolving. Overall, the South Korea Post-Traumatic Stress Disorder Market's Treatment segment reflects a growing understanding of PTSD, emphasizing the need for diverse strategies to cater to a broad demographic, enhancing market growth and patient outcomes.
Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review
Post-Traumatic Stress Disorder Market End Users Insights
The South Korea Post-Traumatic Stress Disorder Market has been increasingly focusing on End Users, primarily through settings such as Ambulatory Surgical Centers, Hospitals, and Clinics. These medical facilities play a critical role in the management and treatment of post-traumatic stress disorder, addressing the mental health needs of the population. Hospitals offer a comprehensive range of services, including inpatient care and specialist consultations, which are vital for severe cases. Clinics, on the other hand, provide outpatient programs that are essential for ongoing therapy and support.
Ambulatory Surgical Centers are becoming significant as they enable quicker procedural interventions for those requiring more immediate care without the need for prolonged hospitalization. The growing awareness around mental health issues in South Korea, alongside government initiatives aimed at improving mental health services, has spurred the demand for more accessible treatment options across these facilities. This development reflects a broader recognition of the importance of treating PTSD effectively, thus enhancing the overall healthcare landscape in the region.The ongoing advancements in treatment modalities and therapeutic practices within these establishments underscore their importance in reducing stigma and improving patient outcomes in mental health care.
South Korea Post-Traumatic Stress Disorder Market Key Players and Competitive Insights
The South Korea Post-Traumatic Stress Disorder Market has seen notable developments in recent years, driven by a growing awareness of mental health issues and the increasing prevalence of PTSD among diverse populations. Competitive insights within this market reveal a landscape characterized by healthcare institutions and research centers that are continuously enhancing their methodologies, therapeutic options, and patient outreach programs.
The collaboration among these entities is critical as they seek to provide comprehensive treatment frameworks that can advance both clinical practice and educational initiatives. Factors such as government support for mental health initiatives and funding for research further bolster the market, creating an environment ripe for innovation and improved healthcare services tailored for PTSD patients.
Pusan National University Hospital stands out in the South Korea Post-Traumatic Stress Disorder Market primarily due to its robust clinical programs focused on mental health. The institution is renowned for its capacity to integrate advanced research with patient care, ensuring that treatments align with the latest psychological findings and evidence-based practices. Its association with one of the leading educational universities in the country allows it to attract highly qualified professionals who are dedicated to trauma-informed care.
Strengths such as a commitment to patient-centered treatment and extensive community outreach enhance its reputation, making Pusan National University Hospital a critical player in addressing PTSD and related mental health concerns within South Korea.Yonsei University Health System offers a comprehensive approach to managing Post-Traumatic Stress Disorder, leveraging its extensive healthcare network and advanced research capabilities to address the complexities of this mental health condition. The system provides a range of services, including specialized counseling, therapy sessions, and innovative treatment options designed for PTSD patients.
With a focus on enhancing the quality of life for individuals suffering from trauma, Yonsei University Health System has strengthened its market presence through strategic partnerships and collaborations. The organization has also engaged in mergers and acquisitions, broadening its capacity to deliver specialized psychosocial interventions and improving access to care across various regions in South Korea.
Furthermore, the emphasis on continuous education and training for healthcare practitioners underlines its commitment to developing effective clinical practices in treating PTSD, solidifying its position as a leading institution in the mental health domain.
Key Companies in the South Korea Post-Traumatic Stress Disorder Market Include:
South Korea Post-Traumatic Stress Disorder Market Industry Developments
In the South Korea Post-Traumatic Stress Disorder Market, recent developments include significant advancements in treatment options and collaborations among leading healthcare institutions. Pusan National University Hospital and Yonsei University Health System are focusing on Research and Development initiatives that focus on innovative therapies for PTSD patients. In June 2023, Daewoong Pharmaceutical announced a partnership with Samsung Medical Center to enhance mental health services, aiming to improve PTSD treatment outcomes.
Furthermore, Asan Medical Center and the Korea Institute for Health and Social Affairs have initiated community outreach programs to raise awareness of PTSD, expanding access to mental health resources. On the financial side, Hanmi Pharmaceutical reported a substantial increase in its market valuation, positively impacting investor confidence in the sector.
Over the past two to three years, particularly from March 2021 to September 2023, substantial funding has been allocated to PTSD research initiatives, reflecting the South Korean government's commitment to mental health. In August 2023, Chonnam National University Hospital partnered with local organizations to implement effective PTSD intervention strategies, highlighting the ongoing collaboration within the healthcare system to tackle this critical issue.
South Korea Post-Traumatic Stress Disorder Market Segmentation Insights
Post-Traumatic Stress Disorder Market Treatment Outlook
Post-Traumatic Stress Disorder Market End Users Outlook
Ambulatory Surgical Centers
Hospitals & Clinics
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2023 | 440.25(USD Million) |
| MARKET SIZE 2024 | 461.75(USD Million) |
| MARKET SIZE 2035 | 1048.58(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.741% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Pusan National University Hospital, Yonsei University Health System, Daewoong Pharmaceutical, Samsung Medical Center, Institute for Mental Health, Asan Medical Center, Hanmi Pharmaceutical, Korea Institute for Health and Social Affairs, Kyungpook National University Hospital, Boryung Pharmaceutical, DongA ST, National Police Agency, Seoul National University Hospital, Chonnam National University Hospital |
| SEGMENTS COVERED | Treatment, End Users |
| KEY MARKET OPPORTUNITIES | Telehealth therapy solutions, Increased awareness campaigns, Innovative treatment modalities, Integrated care programs, Data analytics for treatment efficacy |
| KEY MARKET DYNAMICS | Increasing awareness of PTSD, Rising mental health initiatives, Growing healthcare expenditure, Enhanced treatment options, Stigma reduction efforts |
| COUNTRIES COVERED | South Korea |
Frequently Asked Questions (FAQ) :
The South Korea Post-Traumatic Stress Disorder Market is expected to be valued at 461.75 USD Million in 2024.
In 2035, the South Korea Post-Traumatic Stress Disorder Market is expected to reach a value of 1048.58 USD Million.
The expected CAGR for the South Korea Post-Traumatic Stress Disorder Market from 2025 to 2035 is 7.741%.
In 2024, the psychotherapy segment of the South Korea Post-Traumatic Stress Disorder Market is anticipated to have the largest market share, valued at 150.0 USD Million.
The market value for Prazosin is projected to be 180.0 USD Million in 2035.
Key players in the South Korea Post-Traumatic Stress Disorder Market include Pusan National University Hospital, Yonsei University Health System, and Daewoong Pharmaceutical among others.
Anti-anxiety Medications are expected to generate a revenue of 100.0 USD Million in 2024.
The South Korea Post-Traumatic Stress Disorder Market faces challenges related to stigma and access to treatment options.
The market presents growth opportunities in increasing awareness, advancements in treatment options, and rising mental health initiatives.
The 'Others' treatment segment is expected to reach a value of 98.58 USD Million in 2035.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
